Bavarian Nordic A/S
Bavarian Nordic A/S (BVNKF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BVNKF · as of Jun 8, 2026
Key Statistics
Explore Bavarian Nordic A/S Data
bvnkf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bvnkf competitorsBVNKF
BRCTF
GLPGF
HAWPY
HBMHF
HYPMYStock Performance
Full HistoryAbout Bavarian Nordic A/S
Bavarian Nordic A/S is a biopharmaceutical company primarily focused on the development, production, and commercialization of life-saving vaccines. Its current portfolio of commercialized vaccines inc…
what is bavarian nordic a/s · bvnkf stock overview · bavarian nordic a/s company profile · who is bavarian nordic a/s ceo · bvnkf OTC · bavarian nordic a/s headquarters · bavarian nordic a/s business segments
About Stock Overview & Key Data
Bavarian Nordic A/S (BVNKF) is a Healthcare company in the Biotechnology industry, listed on OTC since Oct 15, 2010. As of the latest trading session, BVNKF stock price is $29.41, with a market capitalization of $2.3B. The stock has returned +6.95% over the past 12 months and -0.31% year-to-date.
In fiscal year 2025, Bavarian Nordic A/S reported revenue of $6.2B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bavarian Nordic A/S (BVNKF) stock price is $29.41. The stock is traded on OTC under the ticker symbol BVNKF. The 52-week range is $26.08 – $37.60.